Evidence map›Paper›PMID 26789134›Full record

ArticleMuscle & nerve2016

Muscle magnetic resonance imaging in congenital myasthenic syndromes.

Sarah Finlayson, Jasper M Morrow, Pedro M Rodriguez Cruz, Christopher D J Sinclair, Arne Fischmann, John S Thornton, Steve Knight, Ray Norbury, Mel White, Michal Al-Hajjar and 6 more

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Muscle & nerve, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06630650 (A Single Center Prospective Natural History and Outcome Measure Validation Study of Congenital Myasthenic Syndromes), which is not on this map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06630650 recruitingnot on this mapstarted 2025, after this paper: background citation

A Single Center Prospective Natural History and Outcome Measure Validation Study of Congenital Myasthenic Syndromes

TypeobservationalSponsorNational Institute of Neurological Disorders and Stroke (NINDS)Ran2025 to 2044Enrolled75ConditionsMyasthenic Syndromes, Congenital
3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Congenital myasthenic syndromes.Orphanet journal of rare diseases · 2019
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Italian recommendations for diagnosis and management of congenital myasthenic syndromes.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2019
    Article
  13. Review
  14. Article
  15. Congenital Myasthenic Syndrome due toEuropean journal of translational myology · 2017
    Article
  16. Clinical features of the myasthenic syndrome arising from mutations in GMPPB.Journal of neurology, neurosurgery, and psychiatry · 2016
    Article
  17. Design and test of a double-nuclear RF coil for (1)H MRI and (13)C MRSI at 7T.Journal of magnetic resonance (San Diego, Calif. : 1997) · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 1 country.

Sarah FinlaysonNuffield Department of Clinical Neurosciences, University of Oxford and Oxford Radcliffe Hospitals NHS Trust, Oxford, UK.
Jasper M MorrowMRC Centre for Neuromuscular Diseases, UCL Institute of Neurology, London, UK.
Pedro M Rodriguez CruzNuffield Department of Clinical Neurosciences, University of Oxford and Oxford Radcliffe Hospitals NHS Trust, Oxford, UK.
Christopher D J SinclairMRC Centre for Neuromuscular Diseases, UCL Institute of Neurology, London, UK.
Arne FischmannMRC Centre for Neuromuscular Diseases, UCL Institute of Neurology, London, UK.
John S ThorntonMRC Centre for Neuromuscular Diseases, UCL Institute of Neurology, London, UK.
Steve KnightUniversity of Oxford Centre for Clinical Magnetic Resonance Research, John Radcliffe Hospital, Oxford, UK.
Ray NorburyUniversity of Oxford Centre for Clinical Magnetic Resonance Research, John Radcliffe Hospital, Oxford, UK.
Mel WhiteDepartment of Paediatrics, University of Oxford and Children's Hospital, Oxford, UK.
Michal Al-HajjarNuffield Department of Clinical Neurosciences, University of Oxford and Oxford Radcliffe Hospitals NHS Trust, Oxford, UK.
Nicola CarboniNeurology Department, Hospital San Francesco of Nuoro, Sardinia, Italy.
Sandeep JayawantDepartment of Paediatrics, University of Oxford and Children's Hospital, Oxford, UK.
Stephanie A RobbDubowitz Neuromuscular Centre, Institute of Child Health and Great Ormond Street Hospital, London, UK.
Tarek A YousryMRC Centre for Neuromuscular Diseases, UCL Institute of Neurology, London, UK.
David BeesonNeurosciences Group, Weatherall Institute of Molecular Medicine, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
Jacqueline PalaceNuffield Department of Clinical Neurosciences, University of Oxford and Oxford Radcliffe Hospitals NHS Trust, Oxford, UK.
University of Oxford · GBMRC Prion Unit · GBGreat Ormond Street Hospital · GBMRC Weatherall Institute of Molecular Medicine · GBOxford University Hospitals NHS Trust · GBUniversity College London · GB

Funding

Medical Research Council MR/M006824/1
6 · The paper itself

Abstract

introductionIn this study we investigated muscle magnetic resonance imaging in congenital myasthenic syndromes (CMS).

methodsTwenty-six patients with 9 CMS subtypes and 10 controls were imaged. T1-weighted (T1w) and short-tau inversion recovery (STIR) 3-Tesla MRI images obtained at thigh and calf levels were scored for severity.

resultsOverall mean the T1w score was increased in GFPT1 and DPAGT1 CMS. T1w scans of the AChR-deficiency, COLQ, and CHAT subjects were indistinguishable from controls. STIR images from CMS patients did not differ significantly from those of controls. Mean T1w score correlated with age in the CMS cohort.

conclusionsMRI appearances ranged from normal to marked abnormality. T1w images seem to be especially abnormal in some CMS caused by mutations of proteins involved in the glycosylation pathway. A non-selective pattern of fat infiltration or a normal-appearing scan in the setting of significant clinical weakness should suggest CMS as a potential diagnosis. Muscle MRI could play a role in differentiating CMS subtypes. Muscle Nerve 54: 211-219, 2016.

Indexed as

Magnetic Resonance ImagingAdolescentAdultFemaleHumansImage Processing, Computer-AssistedMaleMiddle AgedMuscle, SkeletalMyasthenic Syndromes, CongenitalYoung Adultcongenital myastheniadiagnosisgeneticimagingMRImuscle

Identifiers

PMID26789134
PMCPMC4982021
OpenAlexW2289208199

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.